HIMS INVESTORS: Hims & Hers Health, Inc. (NYSE:HIMS) Investors may have been Affected by Fraud – Contact BFA Law by August 25 about Potentially Recovering Losses

Why was Hims & Hers Sued for Securities Fraud? Hims & Hers operates a telehealth platform that provides consumers with access to online consultations with licensed healthcare professionals, prescription medications, and a range of wellness products. On April 29, 2025, Hims & Hers and Novo Nordisk announced a "long-term collaboration" starting with the immediate sale of Novo Nordisk's popular weight loss drug Wegovy on the Hims & Hers platform. The active ingredient in Wegovy is semaglutide. As alleged, Hims ...